We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0JXI market cap is 2.41B. The company's latest EPS is USD -18.9247 and P/E is -15.51.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -94.97M | -206.67M | -242.48M | -293.57M | -380.5M |
| Net Income | -83.95M | -202.24M | -241.85M | -295.35M | -373.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 442.06M | 287M | 273.33M | 362.57M | 640.55M |
| Total Liabilities | 25.49M | 47.03M | 77.23M | 165.18M | 235.21M |
| Total Equity | 416.57M | 239.97M | 196.11M | 197.39M | 405.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -41.62M | -157.56M | -183.92M | -224.86M | -324.23M |
| Investing | 30.71M | 159.78M | -5.06M | 206.69M | -502.52M |
| Financing | 235k | 5.09M | 171.24M | 313.45M | 595.12M |
| Market Cap | 2.41B |
| Price to Earnings Ratio | -15.51 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 57.99 |
| Price to Book Ratio | 14.3 |
| Dividend Yield | - |
| Shares Outstanding | 19.74M |
| Average Volume (1 week) | 147 |
| Average Volume (1 Month) | 102 |
| 52 Week Change | 0.00% |
| 52 Week High | 121.93 |
| 52 Week Low | 121.93 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Madrigal Pharmaceuticals Inc |
| Address |
2711 centerville road wilmington, delaware 19808 |
| Website | https://www.madrigalpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
